Propionic Acid

Propionic Acid

SCHEMBL4166965

CCC(=O)O.CNc1ccc2[nH]c(=O)c3[nH]ccc3c2c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.41
PARP1 P09874 3/20 0.40
TNKS O95271 1/20 0.40
PARP15 Q460N3 1/20 0.40
PARP14 Q460N5 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP12 Q9H0J9 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
PARP4 Q9UKK3 1/20 0.40
PARP3 Q9Y6F1 1/20 0.40
PDE10A Q9Y233 1/20 0.39
TRPM2 O94759 1/20 0.38
BTK Q06187 1/20 0.37
BAZ2B Q9UIF8 1/20 0.37
KDM4E B2RXH2 3/20 0.36
KMT2A Q03164 2/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
ALDH1A1 P00352 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4168329 0.99 BRD4 (0.40) BRD4PARP1TNKSPARP15PARP14
SCHEMBL4717731 0.90 BRD4 (0.39) BRD4PARP1TNKSPARP15PARP14
Propionic Acid SCHEMBL3246304 0.88 KDM4E (0.51) BRD4PARP1TNKSPARP15PARP14
Propionic Acid SCHEMBL4172094 0.87 BRD4 (0.39) BRD4PARP1TNKSPARP15PARP14
Propionic Acid SCHEMBL4159609 0.86 BRD4 (0.45) BRD4
Propionic Acid SCHEMBL3245762 0.84 BRD4 (0.63) BRD4PARP1TNKSPARP15PARP14
Propionic Acid SCHEMBL4158106 0.82 BRD4 (0.60) BRD4
Propionic Acid SCHEMBL4169911 0.82 GABRA1 (0.41) PARP1KDM4EKMT2AALDH1A1HPGD
Propionic Acid SCHEMBL4160624 0.82 MPO (0.43) KDM4E
Propionic Acid SCHEMBL4165125 0.82 PARP1 (0.47) PARP1PDE10ABAZ2BKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRD4 545/4885PARP1 628/4885TNKS 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.